Nextmune AB

Nextmune is a Swedish specialty pharmaceutical company and global leader in allergen-specific immunotherapy (ASIT) for companion animals for over 30 years, present in 70+ countries. Develops and commercializes personalized allergy diagnosis and treatment solutions for dogs, cats and horses. PAX test enables quantitative multiplex diagnosis. 75% immunotherapy efficacy. Acquired ALK's US veterinary activities through Spectrum Veterinary.